NIPH logo

Projects

97 hits
  1. Risk of breast cancer in persons born after assisted reproductive technologies (ART)

    Risk of breast cancer in persons born after assisted reproductive technologies (ART)

    Last update

    This research project is funded by the Norwegian Cancer Society and the Breast Cancer Society with funds from the Pink Ribbon campaign.
    rosa sløyfe
  2. CoMeCT

    CoMeCT

    Last update

    CoMeCT (Coordination Mechanism for Cohorts and Trials) is an ambitious new EU-funded project for coordinating clinical and public health research on infectious diseases with epidemic potential.
  3. Artificial intelligence in BreastScreen Norway - a randomized controlled trial

    Artificial intelligence in BreastScreen Norway - a randomized controlled trial

    Last update

    In this study, we will investigate whether artificial intelligence in combination with radiologists is as good as or better at detecting breast cancer than the current standard procedure in BreastScreen Norway, where two radiologists evaluate the images.
  4. Asbestoscement and cancer risk

    Asbestoscement and cancer risk

    Last update

    This project is a 70-year follow-up of workers and spouses/children of workers at Norway's only asbestos cement factory, which was in operation from around 1945-1981.
  5. BADDI: Artificial intelligence in screening with tomosynthesis

    BADDI: Artificial intelligence in screening with tomosynthesis

    Last update

    The BADDI-project will add knowledge about the use of artificial intelligence to detect breast cancer in screening with tomosynthesis.
  6. SUPPORT-SYSTEMS

    SUPPORT-SYSTEMS

    Last update

    Can decision-making processes for health systems strengthening and universal health coverage (UHC) be made more inclusive, responsive and accountable?
  7. The impact of obesity and circulating small RNA in the development of endometrial cancer

    The impact of obesity and circulating small RNA in the development of endometrial cancer

    Last update

    The project will investigate how age and lifestyle factors affect the expression of circulating small RNA`s among patients with uterine cancer who have submitted samples to the Janus Serum Bank.
  8. Biomarkers for HPV-related cancers

    Biomarkers for HPV-related cancers

    Last update

    This project investigates if biomarkers that can be used to identify an increased risk of cancer related to human papillomavirus infection.
  9. Blueberry

    Blueberry

    Last update

    How can we facilitate the sharing of information about rare cancer diagnoses across Europe while still safeguarding privacy effectively? This is the issue that the BlueBerry project aims to address.
  10. Self-collected specimens in the fight against cervical cancer

    Self-collected specimens in the fight against cervical cancer

    Last update

    In this project, we have demonstrated that a cell sample taken with a home test is just as effective as a cell sample taken by a doctor during a gynecological examination.
  11. CP Study (MOBAND) (project description)

    CP Study (MOBAND) (project description)

    Last update

    The CP Study is based on data from the Norwegian Mother and Child Cohort Study (MoBa) and its Danish equivalent "Bedre Sundhed for Mor og Barn" (BSMB).
    Illustrasjonsfoto: Colourbox.com
  12. CRCbiome epigenome

    CRCbiome epigenome

    Last update

    Changes in DNA methylation patterns can influence how cells grow and divide, potentially contributing to the development of cancer.
  13. Epidemiological study to quantify risks for paediatric computerized tomography and to optimise doses (EPI-CT)

    Epidemiological study to quantify risks for paediatric computerized tomography and to optimise doses (EPI-CT)

    Last update

    The purpose of the study is to establish a European cohort of children under 20 years of age who have undergone one or more CT examinations to estimate the risk of leukemia, other cancer diseases, and other negative health effects.
  14. Exposure-related risks of cancer in petroleum workers

    Exposure-related risks of cancer in petroleum workers

    Last update

    The Cancer Registry has established two cohorts for offshore workers containing information about people who have worked at Norwegian oil platforms from 1965 to until today.
  15. Exposure assessment and disease prevention among offshore workers

    Exposure assessment and disease prevention among offshore workers

    Last update

    The project is anchored at the University of Oslo (UiO), with the Cancer Registry of Norway as collaborating partner.
  16. EQUALSCREEN – Increased attendance and reduced inequity in cervical cancer screening

    EQUALSCREEN – Increased attendance and reduced inequity in cervical cancer screening

    Last update

    In this research project, we will examine whether self-sampling can increase attendance to screening and improve cervical cancer prevention in Norway.
  17. EULAT Eradicate Gallbladder Cancer

    EULAT Eradicate Gallbladder Cancer

    Last update

    EULAT Eradicate Gallbladder Cancer (GBC) aims to improve the prevention, early detection and treatment of gallbladder cancer. The Cancer Registry of Norway is responsible for work package (WP) 3: Novel biomarkers for GBC risk prediction and early detection.
  18. FLORENCE: Federated Learning on Cancer Data

    FLORENCE: Federated Learning on Cancer Data

    Last update

    FLORENCE is an interregional collaboration which, by using hospital and register data harmonized to the OMOP data model, should give colorectal cancer clinicians a better basis for their assessments.
  19. Advantages and disadvantages of artificial intelligence in BreastScreen Norway

    Advantages and disadvantages of artificial intelligence in BreastScreen Norway

    Last update

    Through retrospective studies we will investigate advantages and disadvantages of using artificial intelligence in the assessment of screening mammograms in BreastScreen Norway.
  20. Prevalence of human papillomavirus (HPV) among the population

    Prevalence of human papillomavirus (HPV) among the population

    Last update

    The purpose of the project was to map the extent of HPV among the female population in Norway and in Scandinavia before the first approved HPV vaccine became available on the market in 2006, and 5 years after the introduction of the vaccine.
  21. Research on environmental toxins and cancer

    Research on environmental toxins and cancer

    Last update

    Chlorinated, organic compounds are heavily biodegradable chemical substances that can cause harm to health. The study investigates the relationship between cancer and organochlorins using samples from the Janus serum bank.
  22. Patient reported outcomes after treatment for colorectal cancer – A prospective nationwide study from The Norwegian Colorectal Cancer Registry

    Patient reported outcomes after treatment for colorectal cancer – A prospective nationwide study from The Norwegian Colorectal Cancer Registry

    Last update

    The aim of this project is to evaluate the patient-reported outcomes including functional outcomes, late adverse effects and health-related quality of life in patients treated for colorecal cancer (CRC) in Norway.
  23. Physical activity, cardiorespiratory fitness and cancer

    Physical activity, cardiorespiratory fitness and cancer

    Last update

    By utilizing objectively measured physical fitness, which reflects PA over an extended period, this project aims to contribute to a deeper understanding of the connections between PA and the risk of developing cancer.
  24. About the study Gardasil V501

    About the study Gardasil V501

    Last update

    The results so far indicate that Gardasil is a safe vaccine that provides nearly 100% protection against cervical cell changes caused by the HPV types the vaccine targets for up to 14 years.
  25. About the study Gardasil 9 V503

    About the study Gardasil 9 V503

    Last update

    This long-term study of the Gardasil 9 vaccine will provide information about the vaccine's safety, protection, and duration for up to 14 years after vaccination.